Dr. Bashar İbrahim | Bacteriology | Best Researcher Award

Dr. Bashar İbrahim | Bacteriology – Assistant Professor at Suleyman demirel university, Turkey

Dr. Bashar Ibrahim is a distinguished microbiologist with a profound impact on the field of medical microbiology, infectious diseases, and antimicrobial resistance. With a research career spanning over a decade, he has contributed significantly to understanding bacterial pathogenesis, biofilm formation, and alternative antimicrobial therapies. His work on quorum sensing inhibition, novel antibacterial agents, and infectious disease diagnostics has gained international recognition, making him a leading figure in microbiological research. As an Assistant Professor at Süleyman Demirel University, he has been instrumental in shaping the next generation of microbiologists while simultaneously advancing cutting-edge research.

Professional Profile

Google Scholar  |  Orcid

Education

Dr. Ibrahim pursued his Ph.D. in Medical Microbiology at Eskişehir Osmangazi University, where he conducted groundbreaking research on the prevalence of Campylobacter jejuni in infectious diarrhea. Prior to his doctorate, he completed his Master’s degree in Microbiology at Gazi University, focusing on pre- and post-transplant HEV prevalence in acute leukemia patients undergoing allogeneic transplantation. His academic journey began with a Bachelor’s degree in Biology from Mosul University, where he developed a keen interest in microbial pathogenesis and infectious diseases. His educational background has provided him with a strong foundation for his impactful research in microbiology and immunology.

Experience

Dr. Ibrahim has an extensive academic and research career, currently serving as an Assistant Professor in the Department of Pharmaceutical Microbiology at Süleyman Demirel University. His expertise in microbiology extends beyond academia, as he has actively contributed to research projects and industry collaborations. He plays a vital role in a TÜBİTAK-funded project focused on developing new antimicrobial strategies, demonstrating his ability to lead and innovate in the field. Additionally, he has been involved in scientific peer review, mentoring graduate students, and curriculum development, ensuring that his contributions extend beyond research to education and professional development.

Research Interests

Dr. Ibrahim’s research revolves around infectious disease microbiology, antimicrobial resistance, quorum sensing inhibition, and biofilm formation. His studies have explored natural product-based antimicrobials, investigating their potential to combat drug-resistant pathogens. His work on COVID-19-associated microbial infections has been particularly impactful, shedding light on the microbiological complications of viral diseases. Additionally, he has contributed to pharmaceutical microbiology, focusing on the development of novel antimicrobial formulations and sterility standards for pharmaceutical applications. His research continues to push boundaries in the fight against antimicrobial resistance, making significant strides toward innovative solutions.

Awards

Dr. Ibrahim’s exceptional contributions to microbiological research were recognized when he received the Science Honor Award from the International Academy of Sciences in 2020. This prestigious award acknowledges his groundbreaking research in antibacterial resistance and microbial pathogenesis. His ability to lead high-impact studies and secure research funding has further solidified his reputation as an influential scientist in the global research community.

Publications 📚

1️⃣ Ibrahim B., Reis A., Arin U.E., et al. (2025) – Investigation of the antibacterial activity of Rhamnus cathartica L. and its anti-QS potential on Pseudomonas aeruginosa PAO1 🦠. Natural Product Research.

2️⃣ Ghafil J.A., Al-Sudani S.F.K., Ibrahim B., et al. (2025) – Relationship between biofilm formation of Pseudomonas aeruginosa and susceptibility to rifaximin and ofloxacin 🔬. Pakistan Journal of Pharmaceutical Sciences.

3️⃣ Kurt A.A., Ibrahim B. (2024) – Preparation of New Generation Natural Repellent Formulations From Essential Oils: From Basic Research to Technological Development 🌿. Journal of Cosmetic Science. 📖

4️⃣ Bayraktar N., Elali K., Pehlivan V., Ibrahim B., et al. (2024) – Examination of D-Dimer, Fibrinogen, CRP, and LDH Levels in Serum of Patients with COVID-19 Diabetes Mellitus 🏥. Proceedings of the National Academy of Sciences India Section B – Biological Sciences.

5️⃣ Ibrahim B., Dereli F.T., Erzurumlu Y., et al. (2023) – Anti-Quorum Sensing Activity of Vitis vinifera L. Seed Extract on Some Bacteria: A Greener Alternative Against Antimicrobial Resistance 🍇. Erwerbs-Obstbau Journal.

6️⃣ Öztürk A., Bozok T., Erdoğan M., Ibrahim B., et al. (2023) – COVID-19-associated pulmonary aspergillosis (CAPA): Identification of Aspergillus species and determination of antifungal susceptibility profiles 🦠. Folia Microbiologica.

7️⃣ Bayraktar M., Çetintaş İ., Ibrahim B., et al. (2023) – Evaluation of Microbial Agents in Patients with Chronic Suppurative Otitis Media 🎧. Gevher Nesibe Journal of Medicine and Health Sciences.

Conclusion

Dr. Bashar Ibrahim stands as a remarkable researcher in medical microbiology, pharmaceutical sciences, and infectious disease research. His extensive contributions to antimicrobial resistance, quorum sensing inhibition, and infectious disease microbiology have made a significant impact on the scientific community. With a strong publication record, leadership in research projects, and recognition through prestigious awards, he has established himself as a leading authority in his field. His dedication to advancing microbiological research, mentoring students, and contributing to pharmaceutical sciences makes him an outstanding candidate for the Best Researcher Award. By continuing to expand his research collaborations and focusing on translational applications, Dr. Ibrahim is set to make even greater strides in global scientific innovation. 🚀